Schizophrenia Spectrum and Other Psychotic Disorders Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Schizophrenia Spectrum and Other Psychotic Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

SchizophreniaSchizoaffective DisorderDelusional Disorder+4 more
Beth Israel Deaconess Medical Center320 enrolled6 locationsNCT06740383
Recruiting
Not Applicable

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

Schizophrenia Spectrum and Other Psychotic DisordersAffective Psychoses
King's College London150 enrolled1 locationNCT06568081
Recruiting
Not Applicable

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Bipolar DisorderSevere Mental DisorderSchizophrenia Spectrum and Other Psychotic Disorders+2 more
Bjorn H. Ebdrup84 enrolled1 locationNCT06624462
Recruiting

Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia

SchizophreniaMental DisordersSchizophrenia Spectrum and Other Psychotic Disorders
Central South University200 enrolled1 locationNCT06673966
Recruiting
Not Applicable

Sex, Psychopharmacology, and Diabetes

Diabetes MellitusSexual DysfunctionSchizophrenia+4 more
Zealand University Hospital256 enrolled1 locationNCT05951660
Recruiting
Phase 2

A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults

Schizophrenia Spectrum and Other Psychotic Disorders
Region Örebro County120 enrolled1 locationNCT05622201
Recruiting
Not Applicable

VR-based Avatar Therapy for Treatment of Auditory Hallucinations

Schizophrenia Spectrum and Other Psychotic DisordersHallucinations, Auditory
Semmelweis University90 enrolled4 locationsNCT06505564
Recruiting
Not Applicable

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

SchizophreniaSchizoaffective DisorderDelusional Disorder+3 more
Universitat Autonoma de Barcelona160 enrolled1 locationNCT06423651
Recruiting
Not Applicable

Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia

SmokingSchizophrenia Spectrum and Other Psychotic Disorders
University of Catania260 enrolled1 locationNCT04452175